31 Aug 2026Open access
Development of new imidazopyridine-based chalcones hybrids as potent antidiabetic and antioxidant agents: synthesis, in silico and in vitro evaluationPublisher siteScientific Reports, Aldose Reductase and Taurine
Active, last published 2026
In synthesis and biological activity
Abdulrahman M.
Saleh
Scholar“Research focused on Synthesis and biological activity and adjacent fields.”
Cairo University
Egypt
Claim Your ProfileEgypt18
H-index
864
Citations
Abdulrahman has not officially claimed their profile. If you are Abdulrahman, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
bdulrahman M. Saleh is a researcher working on Synthesis and biological activity. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Abdulrahman's work has been cited 864 times across 4 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Synthesis and biological activity×18Metal complexes synthesis and properties×10Computational Drug Discovery Methods×8Synthesis and Characterization of Heterocyclic Compounds×7Essential Oils and Antimicrobial Activity×6
04 · Where I am
Affiliations
Affiliation on published researchPrincess Nourah bint Abdulrahman University, EgyptDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
23 works3 Aug 2026Open access
Berberine-loaded chitosan nanoparticles protect against radiation-induced premature ovarian failure through modulation of PI3K-PTEN-Akt-FOXO3 pathway and autophagy-inflammasome signalingPublisher siteJournal of Drug Delivery Science and Technology, Reproductive Biology and Fertility
1 Aug 2026Open access
Targeting CDK‐2 With Novel Indole‐Pyrazole Hybrids: Discovery of Potent Anticancer Agents Supported by Mechanistic and In Silico StudiesPublisher siteDrug Development Research, Cancer-related Molecular Pathways
17 Apr 2026
Sertraline-loaded targeted nanocarrier for breast cancer treatment: in vitro and in vivo assessmentPublisher siteJournal of Drug Delivery Science and Technology, Nanoparticle-Based Drug Delivery
7 Apr 2026
Ondansetron-loaded magnetically targeted nanocarriers for anxiety: optimization, in vitro characterization, and in vivo evaluation in ratsPublisher siteEuropean Journal of Pharmaceutics and Biopharmaceutics, Nanoparticle-Based Drug Delivery
26 Feb 2026Open access
Nano-formulated pomegranate extracts with dual cytotoxic and antimicrobial activity: molecular docking and mechanistic insights into leukemia cell targetingPublisher siteBMC Complementary Medicine and Therapies, Pomegranate: compositions and health benefits
26 Feb 2026Open access
Nano-formulated pomegranate extracts with dual cytotoxic and antimicrobial activity: molecular docking and mechanistic insights into leukemia cell targetingPublisher siteFigshare
26 Feb 2026Open access
Additional file 1 of Nano-formulated pomegranate extracts with dual cytotoxic and antimicrobial activity: molecular docking and mechanistic insights into leukemia cell targetingPublisher siteFigshare, Pomegranate: compositions and health benefits
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Abdulrahman?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you